Sumanta Kumar Pal (Sumanta K Pal, Sumanta Pal)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 77

Top Topics

Decision Making

Prognostic Factors

Renal Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature medicine

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov, Nikolay Kislov, Aleksandr Vasiliev, Nils Gunnar Skare, Walter Hong, Stanley Dai, Lily Tang, Anila Qureshi, Jonathan Zalevsky, Mary A Tagliaferri, Daniel J George, Archana M Agarwal, Sumanta Kumar Pal
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, Jasnoor Malhotra, Xiaochen Li, Tanya Barauskas Dorff, Paul Frankel, Marian Llamas-Quitiquit, Joann Hsu, Zeynep B Zengin, Marice Alcantara, Daniela V Castro, Benjamin Mercier, Neal Chawla, Alex Chehrazi-Raffle, Regina Barragan-Carrillo, Salvador Jaime-Casas, Ameish Govindarajan, John Gillece, Jeffery M Trent, Peter P Lee, Thomas P Parks, Motomichi Takahashi, Atsushi Hayashi, Marcin Kortylewski, J Gregory Caporaso, Keehoon Lee, Abhishek Tripathi, Sumanta Kumar Pal
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nature medicine (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 30 (6) (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 30 (6) (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 30 (6) (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Pedro C Barata, Catherine M Tangen, Melissa Plets, Ian M Thompson, Vivek Narayan, Daniel J George, Daniel Y C Heng, Brian M Shuch, Mark N Stein, Shuchi Gulati, Maria Tretiakova, Abhishek Tripathi, Georg Arnold Bjarnason, Peter Humphrey, Adebowale Adeniran, Ulka N Vaishampayan, Ajjai Alva, Tian Zhang, Scott Cole, Primo N Lara, Seth P Lerner, Naomi B Haas, Sumanta Kumar Pal
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov, Nikolay Kislov, Aleksandr Vasiliev, Nils Gunnar Skare, Walter Hong, Stanley Dai, Lily Tang, Anila Qureshi, Jonathan Zalevsky, Mary A Tagliaferri, Daniel J George, Archana M Agarwal, Sumanta Kumar Pal
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 30 (6) (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Cary A Presant, Cathee Till, Riha Vaidya, Kimlin Tan Ashing, Graham W Warren, Virginia Sun, Ravi Salgia, Erminia Massarelli, Joanne E Mortimer, Sumanta Kumar Pal, Tanya Barauskas Dorff, Arya Amini, Loretta Erhunmwunsee, Tanyanika Phillips, Dawn L Hershman, Joseph M Unger
Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants. Cancer (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, Edgar G Kozlova, Kevin G Chan, Sara Lewis, Bassam El Achkar, Tanya B Dorff, Jeremy Paul Cetnar, Brock O Neil, Anishka D'Souza, Ronac Mamtani, Christos E Kyriakopoulos, Tomi Jun, Anisha Mahalya Gogerly-Moragoda, Rachel Brody, Hui Xie, Kai Nie, Geoffrey Kelly, Amir Horowitz, Yayoi Kinoshita, Ethan Ellis, Yohei Nose, Giorgio Ioannou, Rafael Cabal, Diane M Del Valle, G Kenneth Haines, Li Wang, Kent W Mouw, Robert M Samstein, Reza Mehrazin, Nina Bhardwaj, Menggang Yu, Qianqian Zhao, Seunghee Kim-Schulze, Robert P Sebra, Jun Zhu, Sacha Gnjatic, John Sfakianos, Sumanta Kumar Pal
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Nature medicine (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Peter D Zang, Arkhjamil Angeles, Tanya B Dorff, Sumanta Kumar Pal, Shilpa Gupta
Immuno-Oncology Advances in Genitourinary Cancers. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 44 (2) (2024)
Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov, Nikolay Kislov, Aleksandr Vasiliev, Nils Gunnar Skare, Walter Hong, Stanley Dai, Lily Tang, Anila Qureshi, Jonathan Zalevsky, Mary A Tagliaferri, Daniel J George, Archana M Agarwal, Sumanta Kumar Pal
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Daniela V Castro, Sweta R Prajapati, Matthew I Feng, Elyse H Chan, Kyle O Lee, Trishita Paul, Ishaan Sehgal, Jalen Patel, Xiaochen Li, Zeynep B Zengin, Hedyeh Ebrahimi, Ameish Govindarajan, Luis Meza, Benjamin D Mercier, Neal S Chawla, Nazli Dizman, Errol J Philip, JoAnn Hsu, Cristiane D Bergerot, Alex Chehrazi-Raffle, Adam G Rock, Sandy Liu, Abhishek Tripathi, Tanya B Dorff, Sumanta Kumar Pal
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy. BJU international (2023)
Cristiane Decat Bergerot, Sandy Liu, Sumanta Kumar Pal
End-of-Life Care Among Patients With Metastatic Renal Cell Carcinoma: Importance of a Patient-Centric Focus in Clinical Decision Making. JCO oncology practice 19 (2) (2023)
Alex Chehrazi-Raffle, L Elizabeth Elizabeth Budde, Sumanta Kumar Pal
Boosting CAR T cells with anti-tumor mRNA vaccines. Nature medicine (2023)
Jonathan F Anker, Sumanta Kumar Pal, Seunghee Kim-Schulze, Huan Wang, Rebecca Halperin, Andrew Uzilov, Naoko Imai, Shingo Eikawa, Takuro Saito, Robert Sebra, Noah M Hahn, Manishkumar Patel, Jingjing Qi, Hui Xie, Nina Bhardwaj, Sacha Gnjatic, Matthew D Galsky
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. Journal for immunotherapy of cancer 11 (8) (2023)
Cristiane Decat Bergerot, Sandy Liu, Sumanta Kumar Pal
End-of-Life Care Among Patients With Metastatic Renal Cell Carcinoma: Importance of a Patient-Centric Focus in Clinical Decision Making. JCO oncology practice 19 (2) (2023)
Cristiane Decat Bergerot, Sandy Liu, Sumanta Kumar Pal
End-of-Life Care Among Patients With Metastatic Renal Cell Carcinoma: Importance of a Patient-Centric Focus in Clinical Decision Making. JCO oncology practice (2023)
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, Edgar G Kozlova, Kevin G Chan, Sara Lewis, Bassam El Achkar, Tanya B Dorff, Jeremy Paul Cetnar, Brock O Neil, Anishka D'Souza, Ronac Mamtani, Christos E Kyriakopoulos, Tomi Jun, Anisha Mahalya Gogerly-Moragoda, Rachel Brody, Hui Xie, Kai Nie, Geoffrey Kelly, Amir Horwitz, Yayoi Kinoshita, Ethan Ellis, Yohei Nose, Giorgio Ioannou, Rafael Cabal, G Kenneth Haines, Li Wang, Kent W Mouw, Robert M Samstein, Reza Mehrazin, Nina Bhardwaj, Menggang Yu, Qianqian Zhao, Seunghee Kim-Schulze, Robert P Sebra, Jun Zhu, Sacha Gnjatic, John Sfakianos, Sumanta Kumar Pal
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Nature medicine (2023)
Abhishek Tripathi, Daneng Li, Sumanta Kumar Pal
FGFR Inhibition: Understanding and Overcoming Resistance. Cancer discovery 13 (9) (2023)
Cristiane Decat Bergerot, Sandy Liu, Sumanta Kumar Pal
End-of-Life Care Among Patients With Metastatic Renal Cell Carcinoma: Importance of a Patient-Centric Focus in Clinical Decision Making. JCO oncology practice 19 (2) (2023)
Cristiane Decat Bergerot, Sandy Liu, Sumanta Kumar Pal
End-of-Life Care Among Patients With Metastatic Renal Cell Carcinoma: Importance of a Patient-Centric Focus in Clinical Decision Making. JCO oncology practice 19 (2) (2023)
Alexander Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, Smruthy S Sivakumar, Alexa B Schrock, Hannah E Bergom, Hedyeh Ebrahimi, Sumanta Kumar Pal, Tanya Barauskas Dorff, Archana M Agarwal, Brandon A Mahal, Geoffrey R Oxnard, Justin H Hwang, Emmanuel S Antonarakis
Unique spectrum of activating BRAF alterations in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, JoAnn Hsu, Luis Meza, Zeynep B Zengin, Jasnoor Malhotra, Neal Chawla, Tanya Dorff, Tania Contente-Cuomo, Devin Dinwiddie, Bradon R McDonald, Timothy McDaniel, Jeffery M Trent, Frederick L Baehner, Muhammed Murtaza, Sumanta Kumar Pal
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma. JCO precision oncology 7 (2023)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Sumanta Kumar Pal, Diederik M Somford, Petros Grivas, Srikala S Sridhar, Shilpa Gupta, Joaquim Bellmunt, Guru Sonpavde, Mark T Fleming, Seth P Lerner, Yohann Loriot, Jean Hoffman-Censits, Begoña P Valderrama, Corina Andresen, Marco J Schnabel, Suzanne Cole, Siamak Daneshmand
Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial. Future oncology (London, England) 18 (21) (2022)
Sabrina K Salgia, Ameish Govindarajan, Ravi Salgia, Sumanta Kumar Pal
ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready? JCO precision oncology 5 (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Cristiane Decat Bergerot, Sumanta Kumar Pal
Shining a light on the psychological burden of cancer. Nature medicine 28 (4) (2022)
Tanya Barauskas Dorff, Yosuke Hirasawa, Jared Acoba, Ian Pagano, David Tamura, Sumanta Kumar Pal, Minlu Zhang, Rebecca Waitz, Abhilash Dhal, Winston Haynes, John Shon, Mark Scholz, Hideki Furuya, Owen T M Chan, Jeffrey Huang, Charles J Rosser
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T. Journal for immunotherapy of cancer 9 (8) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Nazli Dizman, Luis Meza, Paulo Bergerot, Marice Alcantara, Tanya Dorff, Yung Lyou, Paul Frankel, Yujie Cui, Valerie Mira, Marian Llamas, Joann Hsu, Zeynep Zengin, Nicholas Salgia, Sabrina Salgia, Jasnoor Malhotra, Neal Chawla, Alex Chehrazi-Raffle, Ramya Muddasani, John Gillece, Lauren Reining, Jeff Trent, Motomichi Takahashi, Kentaro Oka, Seiya Higashi, Marcin Kortylewski, Sarah K Highlander, Sumanta Kumar Pal
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nature medicine 28 (4) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Mahul B Amin, Jesse K McKenney, Guido Martignoni, Steven C Campbell, Sumanta Kumar Pal, Satish K Tickoo
Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (10) (2022)
Luis Meza, Ameish Govindarajan, Matthew Feng, Sumanta Kumar Pal
Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma. Clinical and translational medicine 12 (7) (2022)
Sarmad Sadeghi, David I Quinn, Tanya Dorff, Sumanta Kumar Pal, Susan Groshen, Denice Tsao-Wei, Rahul A Parikh, Michael Devitt, Mamta Parikh, Alexandra Jackovich, Nora Ruel, Nicholas J Vogelzang, Earle Burgess, Imran Siddiqi, Inderbir S Gill, Primo N Lara, Robert Dreicer, Parkash S Gill
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Alexander Chehrazi-Raffle, Luis Meza, Marice Alcantara, Nazli Dizman, Paulo Bergerot, Nicholas Salgia, JoAnn Hsu, Nora Ruel, Sabrina Salgia, Jasnoor Malhotra, Ewa Karczewska, Marcin Kortylewski, Sumanta Kumar Pal
Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma. Journal for immunotherapy of cancer 9 (3) (2021)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, Ulka Vaishampayan, Sumanta Kumar Pal, Yousef Zakharia, Heather S L Jim, Mayer N Fishman, Ana M Molina, Christos E Kyriakopoulos, Che-Kai Tsao, Leonard J Appleman, Benjamin A Gartrell, Arif Hussain, Walter M Stadler, Neeraj Agarwal, Russell K Pachynski, Thomas E Hutson, Hans J Hammers, Christopher W Ryan, Brant A Inman, Jack Mardekian, Azah Borham, Daniel J George
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC). Cancer 127 (13) (2021)
Gennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, James Brugarolas, Mark W. Ball, Adam Metwalli, Katherine L Nathanson, Phillip M Pierorazio, Ronald S Boris, Eric A Singer, Maria I Carlo, Mary B Daly, Elizabeth P Henske, Colette Hyatt, Lindsay Middleton, Gloria Morris, Anhyo Jeong, Vivek Narayan, W Kimryn Rathmell, Ulka N Vaishampayan, Bruce H Lee, Dena Battle, Michael J Hall, Khaled Hafez, Michael A S Jewett, Christina Karamboulas, Sumanta Kumar Pal, A Ari Hakimi, Alexander Kutikov, Othon Iliopoulos, W Marston Linehan, Eric Jonasch, Ramaprasad Srinivasan, Brian M Shuch
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement. Cancer 127 (21) (2021)
Kevin Shee, Sumanta Kumar Pal, J Connor Wells, Jose Manuel Ruiz-Morales, Kenton Russell, Shaan Dudani, Toni K Choueiri, Daniel Y C Heng, John L Gore, Anobel Y Odisho
Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer. JCO clinical cancer informatics 5 (2021)
Diego Abreu, Gustavo Carvalhal, Guillermo Gueglio, Ignacio Tobia, Patricio Garcia, Alvaro Zuñiga, Luis Meza, Rubén Bengió, Carlos Scorticati, Ricardo Castillejos, Francisco Rodriguez, Ana Maria Autrán Gómez, Carmen González Enguita, Jose Gadu, Alejandro Nolazco, Carlos Ameri, Hamilton Zampolli, Raúl Langenhin, Diego Muguruza, Marcos Tobías Machado, Pablo Mingote, Juan Yandian, Jorge Clavijo, Lucas Mendes Nogueira, Omar Clark, Fernando Secin, Agustín Rovegno, Ana Vilas, Enrique Barrios, Ricardo Decia, Gustavo Cardoso Guimarães, Sidney Glina, Sumanta Kumar Pal, Oscar Rodriguez, Joan Palou, Philippe Spiess, Primo N Lara, W Marston Linehan, Antonio Luigi Pastore, Stenio de Cassio Zequi
Prognostic Factors in De Novo Metastatic Renal Cell Carcinoma: A Report From the Latin American Renal Cancer Group. JCO global oncology 7 (2021)
Nicholas J Salgia, Alexander Chehrazi-Raffle, JoAnn Hsu, Zeynep Zengin, Sabrina Salgia, Neal S Chawla, Luis Meza, Jasnoor Malhotra, Nazli Dizman, Ramya Muddasani, Nora Ruel, Mary Cianfrocca, Jun Gong, Sidharth Anand, Victor Chiu, James Yeh, Sumanta Kumar Pal
Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California. Cancer medicine 10 (16) (2021)
Chun Loo Gan, Shaan Dudani, J Connor Wells, Frede Donskov, Sumanta Kumar Pal, Nazli Dizman, Nityam Rathi, Benoit Beuselinck, Flora Yan, Aly-Khan A Lalani, Aaron Richard Hansen, Bernadett Szabados, Guillermo de Velasco, Ben Tran, Jae Lyun Lee, Ulka N Vaishampayan, Georg A Bjarnason, Mathushan Subasri, Toni K Choueiri, Daniel Y C Heng
Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Cancer medicine 10 (4) (2021)
Luis Meza, Jasnoor Malhotra, Crystal Favorito, Sumanta Kumar Pal
Cabozantinib plus immunotherapy combinations in metastatic renal cell and urothelial carcinoma. Future oncology (London, England) 18 (1) (2021)
Sumanta Kumar Pal, Bradley Alexander McGregor, Cristina Suárez, Che-Kai Tsao, William Kelly, Ulka N Vaishampayan, Lance Pagliaro, Benjamin L Maughan, Yohann Loriot, Daniel Castellano, Sandy Srinivas, Rana R McKay, Robert Dreicer, Thomas E Hutson, Sarita Dubey, Scott Werneke, Ashok Panneerselvam, Dominic Curran, Christian Scheffold, Toni K Choueiri, Archana M Agarwal
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)
Justine Abella Ross, Kellie Komoda, Sumanta Kumar Pal, Jana K Dickter, Ravi Salgia, Sanjeet Singh Dadwal
Infectious complications of immune checkpoint inhibitors in solid organ malignancies. Cancer medicine (2021)
Rohit K Jain, Petros Grivas, Sumanta Kumar Pal
Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet? BJU international 124 (3) (2020)
Russell W Madison, Sumati V Gupta, Yasir Y Elamin, Douglas I Lin, Sumanta Kumar Pal, Andrea Necchi, Vincent A Miller, Jeffrey S Ross, Jon H Chung, Brian M Alexander, Alexa B Schrock, John V Heymach, Prasanth Reddy, Siraj M Ali
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions. BJU international 125 (5) (2020)
Karen L Reckamp, Jasmine A McQuerry, Isa Mambetsariev, Rebecca R Pharaon, Susan E Yost, Jeremy Fricke, Tamara Mirzapoiazova, Raju K Pillai, Ziad Khan, Marwan G Fakih, Yuan Yuan, Marianna Koczywas, Erminia Massarelli, Prakash Kulkarni, Sumanta Kumar Pal, Martin Sattler, Andrea Bild, Ravi Salgia
Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations. Future science OA 7 (2) (2020)
Cristiane Decat Bergerot, Errol J Philip, Paulo Gustavo Bergerot, JoAnn Hsu, Nazli Dizman, Megan Salgia, Nicholas Salgia, Ulka N Vaishampayan, Dena Battle, Matthew Loscalzo, William Dale, Sumanta Kumar Pal
Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status. Cancer 127 (3) (2020)
Andrea B Apolo, Rosa Nadal Rios, Daniel M Girardi, Scot A Niglio, Lisa Ley, Lisa M Cordes, Seth M Steinberg, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Diaz, Marissa Mallek, Nicole N Davarpanah, Rene Costello, Jane B Trepel, Min-Jung Lee, Maria J Merino, Mohammad Hadi Bagheri, Paul Monk, William D Figg, James L Gulley, Piyush K Agarwal, Vladimir Valera, Heather J Chalfin, Jennifer C Jones, Howard Streicher, John J Wright, Yangmin M Ning, Howard L Parnes, William L Dahut, Donald P Bottaro, Primo N Lara, Biren Saraiya, Sumanta Kumar Pal, Mark N Stein, Amir Mortazavi
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (31) (2020)
Ali Raza Khaki, Neeraj Agarwal, Sumanta Kumar Pal, Petros D Grivas
Immunotherapy-based combination strategies for advanced urothelial cancer: A long quest. Cancer 126 (20) (2020)
Cristiane Decat Bergerot, Marianne Razavi, Errol J Philip, Paulo Gustavo Bergerot, Marco M Buso, Karen Lynn Clark, Matthew Loscalzo, Sumanta Kumar Pal, William Dale
Association between hospital anxiety and depression scale and problem-related distress in patients with cancer in a Brazilian private institution. Psycho-oncology 30 (3) (2020)
Nazli Dizman, JoAnn Hsu, Paulo G Bergerot, John D Gillece, Megan Folkerts, Lauren Reining, Jeffrey Trent, Sarah K Highlander, Sumanta Kumar Pal
Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma. Cancer medicine 10 (1) (2020)
Sumanta Kumar Pal, David F McDermott, Michael B Atkins, Bernard Escudier, Brian I Rini, Robert J Motzer, Lawrence Fong, Richard W Joseph, Stephane Oudard, Alain Ravaud, Sergio Bracarda, Cristina Suárez, Elaine T Lam, Toni K Choueiri, Beiying Ding, Caroleen Quach, Kenji Hashimoto, Christina Schiff, Elisabeth Piault-Louis, Thomas Powles
Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma. BJU international 126 (1) (2020)
Yueyao Li, Michael S Hendryx, Pengcheng Xun, Ka He, Aladdin H Shadyab, Dorothy S Lane, Rami Nassir, Marcia L Stefanick, Jean Wactawski-Wende, Sumanta Kumar Pal, Juhua Luo
Physical activity and risk of bladder cancer among postmenopausal women. International journal of cancer 147 (10) (2020)
Sumanta Kumar Pal, Dean Bajorin, Nazli Dizman, Jean Hoffman-Censits, David I Quinn, Daniel P Petrylak, Matthew D Galsky, Ulka N Vaishampayan, Ugo De Giorgi, Sumati Gupta, Howard A Burris, Harris S Soifer, Gary Li, Hao Wang, Carl L Dambkowski, Susan Moran, Siamak Daneshmand, Jonathan E Rosenberg
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results. Cancer 126 (11) (2020)
Cristiane Decat Bergerot, Dena Battle, Errol J Philip, Paulo Gustavo Bergerot, Pavlos Msaouel, Allan 'Ben' Smith, Adeola Esther Bamgboje, Brian Shuch, Ithaar H Derweesh, Eric Jonasch, Adam P Stern, Sumanta Kumar Pal, Michael D Staehler
Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma. JCO oncology practice 16 (11) (2020)
Alberto Martini, Rachel Jia, Bart S Ferket, Nikhil Waingankar, Elizabeth R Plimack, Simon J Crabb, Lauren C Harshman, Evan Y Yu, Thomas Powles, Jonathan E Rosenberg, Sumanta Kumar Pal, Ulka N Vaishampayan, Andrea Necchi, N Peter Wiklund, Reza Mehrazin, Madhu Mazumdar, John P Sfakianos, Matthew D Galsky
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer. Cancer 125 (18) (2019)
Guru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, Rebecca J Nagy, Roberto H Nussenzveig, Andrew W Hahn, Oliver Sartor, Theodore Stewart Gourdin, Lakshminarayanan Nandagopal, Elisa M Ledet, Gurudatta Naik, Andrew J Armstrong, Jue Wang, Mehmet Asim Bilen, Shilpa Gupta, Petros Grivas, Sumanta Kumar Pal, Richard B Lanman, AmirAli Talasaz, Michael B Lilly
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer. Cancer 125 (9) (2019)
Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, Jo Ann Hsu, Nazli Dizman, Ulka Vaishampayan, Tanya Dorff, Sumanta Kumar Pal
Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy. Journal for immunotherapy of cancer 7 (1) (2019)
Cristiane Decat Bergerot, Dena Battle, Michael D Staehler, Sumanta Kumar Pal
Distress in patients with renal cell carcinoma: a curious gap in knowledge. BJU international 123 (2) (2018)
Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, Edvane Birelo Lopes De Domenico, Maria Fernanda Marcusso Manhaes, Renata Nunes Pedras, Meghan M Salgia, Nazli Dizman, Kimlin Tan Ashing, Min Li, William Dale, Sumanta Kumar Pal
Assessment of distress and quality of life in rare cancers. Psycho-oncology 27 (12) (2018)